发明名称 |
HETEROARYLOXY QUINAZOLINE DERIVATIVES |
摘要 |
Disclosed is a compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof, which has a glucokinase activating effect and is thus useful for treatment of diabetes, obesity and the like. (In the formula (I), ring A represents a pyrazolyl group which may have a lower alkyl group or the like; ring B represents a heteroaryl group; R represents a lower alkyl group or the like; R1 represents a group represented by the formula (II-1) below or the like; R2 represents a lower alkyl group or the like; r represents an integer of 0-3; and k represents an integer of 0-4.) (In the formula (II-1), R11 and R12 independently represent a hydrogen atom or the like; and m represents an integer of 2-6.) |
申请公布号 |
CA2705370(A1) |
申请公布日期 |
2009.05.22 |
申请号 |
CA20082705370 |
申请日期 |
2008.11.10 |
申请人 |
BANYU PHARMACEUTICAL CO., LTD. |
发明人 |
ASAI, MASANORI;IINO, TOMOHARU;SUGA, TAKUYA;OHNO, AKIO;OHTAKE, NORIKAZU |
分类号 |
C07D401/14;A61K31/517;A61K38/22;A61K38/28;A61K45/00;A61P3/10;A61P9/10;A61P13/12;A61P25/00;A61P27/00;A61P43/00;C07D417/14;C07D513/04 |
主分类号 |
C07D401/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|